| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.01 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |